Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe history shows a new revision entry (v3.3.4) added and the previous revision (v3.3.3) removed, indicating a minor update to the study's record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new 'Study Status' entry was added to the record history (Version 53, Revision: v3.3.3) on 2025-12-17. The 'HHS Vulnerability Disclosure' footer link was removed (Revision: v3.3.2) on 2025-12-15.SummaryDifference0.3%

- Check32 days agoChange DetectedNew history entries include a Study Status addition on 2025-12-15 and a 52-item update on 2025-12-09, with a deletion recorded on 2025-11-24. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedA new 'Study Status' section and revision metadata (Revision: v3.3.2) were added on 2025-11-24, while an older revision (v3.2.0) was deleted. No core study data or results were changed.SummaryDifference0.3%

- Check61 days agoChange DetectedThe government funding/operating status notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe new screenshot mirrors the old one, showing the same Version history and study details. Only minor UI/layout differences are visible between the two images. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.